237 related articles for article (PubMed ID: 23865864)
1. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.
Xu M; Ju W; Hao H; Wang G; Li P
Drug Metab Rev; 2013 Aug; 45(3):311-52. PubMed ID: 23865864
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors.
Jiang JG; Chen CL; Card JW; Yang S; Chen JX; Fu XN; Ning YG; Xiao X; Zeldin DC; Wang DW
Cancer Res; 2005 Jun; 65(11):4707-15. PubMed ID: 15930289
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytochrome P450 arachidonic acid epoxygenase 2J2 in human tumor tissues and cell lines.
Jiang JG; Fu XN; Chen CL; Wang DW
Ai Zheng; 2009 Feb; 28(2):93-6. PubMed ID: 19550113
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes.
Aliwarga T; Evangelista EA; Sotoodehnia N; Lemaitre RN; Totah RA
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966295
[TBL] [Abstract][Full Text] [Related]
5. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
6. Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Ren S; Zeng J; Mei Y; Zhang JZ; Yan SF; Fei J; Chen L
Drug Metab Dispos; 2013 Jan; 41(1):60-71. PubMed ID: 23033255
[TBL] [Abstract][Full Text] [Related]
7. Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes.
Nakayama K; Nitto T; Inoue T; Node K
Life Sci; 2008 Aug; 83(9-10):339-45. PubMed ID: 18675280
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.
Liu PY; Li YH; Chao TH; Wu HL; Lin LJ; Tsai LM; Chen JH
Atherosclerosis; 2007 Nov; 195(1):199-206. PubMed ID: 17126841
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome p450 epoxygenase promotes human cancer metastasis.
Jiang JG; Ning YG; Chen C; Ma D; Liu ZJ; Yang S; Zhou J; Xiao X; Zhang XA; Edin ML; Card JW; Wang J; Zeldin DC; Wang DW
Cancer Res; 2007 Jul; 67(14):6665-74. PubMed ID: 17638876
[TBL] [Abstract][Full Text] [Related]
10. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
Spiecker M; Darius H; Hankeln T; Soufi M; Sattler AM; Schaefer JR; Node K; Börgel J; Mügge A; Lindpaintner K; Huesing A; Maisch B; Zeldin DC; Liao JK
Circulation; 2004 Oct; 110(15):2132-6. PubMed ID: 15466638
[TBL] [Abstract][Full Text] [Related]
11. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.
Shahabi P; Siest G; Meyer UA; Visvikis-Siest S
Pharmacol Ther; 2014 Nov; 144(2):134-61. PubMed ID: 24882266
[TBL] [Abstract][Full Text] [Related]
12. CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.
Li R; Xu X; Chen C; Wang Y; Gruzdev A; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E270-82. PubMed ID: 25389363
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease.
Spiecker M; Liao J
Trends Cardiovasc Med; 2006 Aug; 16(6):204-8. PubMed ID: 16839864
[TBL] [Abstract][Full Text] [Related]
14. Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
Chen F; Chen C; Yang S; Gong W; Wang Y; Cianflone K; Tang J; Wang DW
PLoS One; 2012; 7(6):e39197. PubMed ID: 22761738
[TBL] [Abstract][Full Text] [Related]
15. CYP2J2 - regulation, function and polymorphism.
Murray M
Drug Metab Rev; 2016 Aug; 48(3):351-68. PubMed ID: 27286171
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia.
Moshal KS; Zeldin DC; Sithu SD; Sen U; Tyagi N; Kumar M; Hughes WM; Metreveli N; Rosenberger DS; Singh M; Vacek TP; Rodriguez WE; Ayotunde A; Tyagi SC
J Cell Physiol; 2008 Jun; 215(3):771-81. PubMed ID: 18181170
[TBL] [Abstract][Full Text] [Related]
17. Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors.
Leow JWH; Verma RK; Lim ABH; Fan H; Chan ECY
Eur J Pharm Sci; 2021 Sep; 164():105889. PubMed ID: 34044117
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 2J2: Potential Role in Drug Metabolism and Cardiotoxicity.
Solanki M; Pointon A; Jones B; Herbert K
Drug Metab Dispos; 2018 Aug; 46(8):1053-1065. PubMed ID: 29695613
[TBL] [Abstract][Full Text] [Related]
19. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
[TBL] [Abstract][Full Text] [Related]
20. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
Shahabi P; Siest G; Visvikis-siest S
Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]